News
-
-
PRESS RELEASE
Zomedica Launches Quantitative Insulin Assay for Equine Plasma on the TRUFORMA(R) Platform
Zomedica launches TRUFORMA Insulin assay for equine plasma, providing rapid results in 18 minutes for diagnosing and monitoring insulin levels in horses, aiding in treatment decisions for equine metabolic syndrome and PPID -
-
-
-
-
-
PRESS RELEASE
Zomedica Announces Third Quarter 2024 Financial Results: Revenue Up 10% to $7 Million; 72% Gross Margin, and $78 Million in Liquidity to Support Growth
Zomedica Corp. reports record third-quarter revenue growth of 10%, driven by strong performance in Diagnostics and Capital segments. International expansion and positive outlook for 2025 highlighted by CEO Larry Heaton -
-